Small Airway Disease in Asthma and COPD Clinical Implications

被引:143
|
作者
van den Berge, Maarten [1 ]
ten Hacken, Nick H. T. [1 ]
Cohen, Judith [1 ]
Douma, W. Rob [1 ]
Postma, Dirkje S. [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, NL-9713 GZ Groningen, Netherlands
关键词
OBSTRUCTIVE PULMONARY-DISEASE; MESSENGER-RNA EXPRESSION; FORCED VITAL CAPACITY; BECLOMETHASONE DIPROPIONATE; PERIPHERAL AIRWAYS; LUNG-FUNCTION; NITRIC-OXIDE; HYDROFLUOROALKANE-134A BECLOMETHASONE; FLUTICASONE PROPIONATE; COMPUTED-TOMOGRAPHY;
D O I
10.1378/chest.10-1210
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Asthma and COPD have a high personal, societal, and economic impact. Both diseases are characterized by airway obstruction and an inflammatory process. The inflammatory process affects the whole respiratory tract, from central to peripheral airways that are <2 mm in internal diameter, the so-called small airways. There is an increased interest in small airway disease, and some new insights have been gained about the contribution of these small airways to the clinical expression of asthma and COPD, as reviewed in this article. Newly developed devices enable drugs to target the small airways, and this may have implications for treatment of patients with asthma, particularly those not responding to large-particle inhaled corticosteroids or those with uncontrollable asthma. The first studies in COPD are promising, and results from new studies are eagerly awaited. CHEST 2011; 139(2):412-423
引用
收藏
页码:412 / 423
页数:12
相关论文
共 50 条
  • [21] Airway Remodeling in Patients with Asthma and Chronic Obstructive Pulmonary Disease (COPD).
    Krenke, R.
    Kosciuch, J.
    Gorska, K.
    Przybylowski, T.
    Baran, W.
    Kujawa, M.
    Hildebrand, K.
    Chazan, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [22] Asthma and smoking-induced airway disease without spirometric COPD
    Thomson, Neil C.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (05)
  • [23] Computed tomography for evaluation of the small airway disease in asthma
    Fuso, Leonello
    Condoluci, Carola
    Conte, Emanuele
    Angeletti, Giulia
    Contu, Chiara
    Macis, Giuseppe
    Sbarra, Martina
    Montuschi, Paolo
    Valente, Salvatore
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [24] Small-airway disease in asthma: pharmacological considerations
    Usmani, Omar S.
    CURRENT OPINION IN PULMONARY MEDICINE, 2015, 21 (01) : 55 - 67
  • [25] Small airway disease in asthma: pathophysiological and diagnostic considerations
    Contoli, Marco
    Santus, Pierachille
    Papi, Alberto
    CURRENT OPINION IN PULMONARY MEDICINE, 2015, 21 (01) : 68 - 73
  • [26] Small Airway Disease in Asthma: Why is it so Important?
    Baraldi, F.
    Alfano, F.
    Contoli, M.
    Papi, A.
    ARCHIVOS DE BRONCONEUMOLOGIA, 2022, 58 (06): : 471 - 473
  • [27] The clinical features of asthma-COPD overlap syndrome compared to asthma with irreversible airway obstruction
    Olga, Kharevich
    Irina, Lapteva
    Elena, Lapteva
    Elena, Koroleva
    Natalia, Shpakouskaya
    Dmitry, Kovalenko
    Marina, Dzusmikeeva
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [28] Therapeutic implications of diagnosing small airway disease
    Etienne, Samuel
    Stolz, Daiana
    ZEITSCHRIFT FUR PNEUMOLOGIE, 2024, 21 (05): : 298 - 301
  • [29] Pharmacology of airway inflammation in asthma and COPD
    Caramori, G
    Adcock, I
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2003, 16 (05) : 247 - 277
  • [30] Airway remodelling in COPD: It's not asthma!
    Jones, Robyn L.
    Noble, Peter B.
    Elliot, John G.
    James, Alan L.
    RESPIROLOGY, 2016, 21 (08) : 1347 - 1356